home - theme - highlights - programme - social events - call for papers - booking - press releases - awards

 

 
Programme        
PROGRAMME LINKS
Monday - Tuesday - Wednesday
  
am Monday 10 September
       
 

10.45 – 11.30 COFFEE, TEA, OFFICIAL OPENING OF THE EXHIBITION AND BPC-PJ CAREERS FORUM
           
 

The science of pharmacy

  

Science into practice

  

The practice of pharmacy
           
      9.15 – 9.25
President’s welcome
President, Royal Pharmaceutical Society of Great Britain		    
           
 

  9.25 – 10.45
The medicines maze: balancing risks and benefits
Sponsored by Boots logo		    
    In the chair: President, Royal Pharmaceutical Society of Great Britain    
    Balancing scientific risks
Professor Sir Colin Dollery, Senior Consultant, GlaxoSmithKline		    
      Getting the regulation right
Professor Kent Woods, Medicines and Healthcare products Regulatory Agency		    
      Choosing well: enabling patients to get it right
Harry Cayton, Department of Health		    
           
      11.30 – 12.30
2007 Conference Science and Practice Chairmen’s Addresses
In the chair: President, Royal Pharmaceutical Society of Great Britain		    
      Joined up thinking
Professor Clive Wilson, Science Chairman, BPC 2007		  

      To be or not to be taken? That is the question
Professor Theo Raynor, Practice Chairman, BPC 2007		    
           
 

12.30 – 13.30 LUNCH, EXHIBITION, BPC-PJ CAREERS FORUM AND POSTERS
 
fringe sessions
12.30-1.30

The electronic patient record; facilitating new pharmacovigilance techniques
Jointly hosted by and
Access to national electronic patient records should offer great opportunities to improve pharmacovigilance. This fringe session with look at what the risks and benefits might be, and the practical considerations in implementing new techniques. For further information click here.
 
      pm Monday 10 September
 

14.30 – 15.00 COFFEE, TEA, EXHIBITION, BPC-PJ CAREERS FORUM AND POSTERS
 

The science of pharmacy

  

Science into practice

  

The practice of pharmacy
           
      13.30 – 14.00
Ministerial address
In the chair: President, Royal Pharmaceutical Society of Great Britain		  

 

  Lord Hunt of Kings Heath, Minister of State for Quality, Department of Health  

       

    14.00 – 14.30
President’s address
In the chair: Vice-President, Royal Pharmaceutical Society of Great Britain		  

    President, Royal Pharmaceutical Society of
Great Britain		  

       

15.00 – 17.00
A choice of:
      15.00 – 17.00
Getting the message across:
communicating risk and benefit to patients
In the chair: Joanne Rule, CancerBackup		  

Statins as an early intervention:
public health versus individual choice
In the chair: Professor Jim Smith, University of Sunderland
  15.00 – 17.00
A choice of:		   Talking to patients
David Dickinson, Consumation		   The case for statins as an early
intervention
  Risk management: the key to pharmaceutical quality   Communicating the chance of benefits and risk
Dr Peter Knapp, University of Leeds		  

Dr Rubin Minhas, GP with a Special Interest in Coronary Heart Disease
  In association with the Joint Pharmaceutical Analysis Group   Do the media promote the public misunderstanding of science?
Dr Ben Goldacre, The Guardian		  

Is it just a gamble?
Chris Brewer, North Cumbria Acute
Hospitals NHS Trust
  In the chair: Ken J Leiper, Benson Associates      

Weighing up the costs and benefits
Professor Stirling Bryan, University of
Birmingham
  PAT, cGMP for the 21st Century and ICHQ9
Dr Ajaz Hussain, Sandoz		       Living with the decisions
Dr Peter Elton, Bury PCT
  What is the discriminating measurement actually capable of
discriminating?
Dr Steve Hammond, Pfizer Global Manufacturing		  

 

  

Or
Squaring the circle: protecting
pharmacists and patients
  Just how representative is your sample and what are the consequences?
Dr David Rudd, GlaxoSmithKline International Quality Assurance		    

Sponsored by 

In the chair: Olivia Timbs, The
Pharmaceutical Journal
  Material functionality by design: a different approach to risk management
Dr Rob Price, University of Bath		    

The advantages and disadvantages of no blame (or fair blame) culture
Speakers will include:
Dr Bruce Warner, National Patient Safety
Agency
Professor Joy Wingfield, University of
Nottingham
John Murphy, The Pharmacists’ Defence
Association
           
  Or      

Or
  Therapeutic biomolecules and vaccines: reducing future risk      

Workforce and education:
perceptions on the journey from
student to health care professional
  In association with the Academy of Pharmaceutical Sciences      

Selected papers in practice research
  In the chair: Dr Barry Moore, University of Strathclyde and Dr Kevin King, Pfizer UK      

In the chair: Professor Christine Bond,
University of Aberdeen and Dr Philip Rogers, University of Bath
  Spin doctors: meeting clinical need in biologic product development
Professor Richard Ross, University of Sheffield		      

Or
Hot topic
  Risk mitigation in formulation development
Dr Andrew Lewis, Critical Pharmaceuticals		      

In the chair: to be announced
Discussion on the White Paper Trust,
Assurance and Safety: The Regulation of
Health Professionals in the 21st Century.
  The matrix refolded! Engineering enhanced protein formulation robustness
Professor Robert Forbes, University of Bradford		      

 
17.30 – 18.00
Practice debate
  Understanding the interaction between antigen and adjuvant in anthrax sub-unit vaccine
Dr Allan Watkinson, Avecia		       Friend or foe? The media’s reporting
of risks and benefits
In the chair: Professor Carmel Hughes,
Queen’s University Belfast
         

Olivia Timbs, The Pharmaceutical Journal
Versus
Dr Ben Goldacre, The Guardian
  Or      

  Predicting safety benefits and risks in drug development      

  In association with European Federation for Pharmaceutical Sciences      

  In the chair: Professor Daan J. A. Crommelin, University of Utrecht, The
Netherlands		      

  Modelling: Mechanism-based PK-PD Modelling for prediction of efficiency and safety
Professor Meindert Danhof, Leiden Amsterdam Centre for Drug Research, The Netherlands		      
  Microdosing
Professor Anders Grahnen, University of Uppsala and Quintiles, Sweden		      
  Excipients
Dr Klaus Olejniczac, BfArM, Germany		      
  Biopharmaceuticals and immunogenicity
Professor Daan J. A. Crommelin, University of Utrecht, The Netherlands		      
         

  Or      

  Short talks in pharmaceutics
For further information, click here		      

  In the chair: Professor Martin Snowden, University of Greenwich and Dr Laura Waters, University of Huddersfield      

         

  17.00 – 17.30
Academy of Pharmaceutical Sciences Keynote Lecture		      

  Sponsored by      

  Professor Nigel Brown, Director, Biotechnology and Biological Sciences Research Council      

         

  17.30 – 18.00
Attended science poster session incorporating wine reception and poster prize presentation		  

 

  Sponsored by       

         

  18.00 – 18.30
Science debate		      

  Homeopathy or allopathy: which one would you choose?  

 

  

  In the chair: Professor Clive Wilson, Science Chairman, BPC 2007
Professor David Colquhoun, University College London		  

 

  

  Versus
Felicity Lee, Homeopathic Practitioner
 		      

 

20.00 CONFERENCE DINNER. With after-dinner speaker Martyn Lewis, Newsreader
22.00 approx. DANCING TO THE RIGHT STUFF
           
  Top of Page ↑      

           
 
PROGRAMME LINKS
Monday - Tuesday - Wednesday
 		  

   
 

home - theme - highlights - programme - social events - call for papers - booking - press releases - awards